Developing human biomonitoring as a 21st century toolbox within the European exposure science strategy 2020–2030
Autor(a) principal: | |
---|---|
Data de Publicação: | 2022 |
Outros Autores: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | http://hdl.handle.net/10362/143991 |
Resumo: | Funding Information: The authors are grateful to all experts from academia, institutes and industry that have participated in discussions that helped formulate the present strategy paper. They would also like to thank ISES Europe for initiating the discussions to prepare a European Exposure Science Strategy 2030. The German Federal Institute for Occupational Safety and Health (BauA), National Institute for Public Health and the Environment (RIVM) and the European Commission Joint Research Centre (JRC) are also acknowledged for each hosting of a meeting in 2018, 2019 and 2020 respectively during which the foundations of the current strategy were built. The views expressed are those of the authors alone and do not necessarily reflect those of the organisations at which they are employed. Publisher Copyright: © 2022 The Authors |
id |
RCAP_ffb124fbe338b9683ece95d3fc26bec4 |
---|---|
oai_identifier_str |
oai:run.unl.pt:10362/143991 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
Developing human biomonitoring as a 21st century toolbox within the European exposure science strategy 2020–2030Chemicals mixturesCircular economyData governanceHuman biomonitoringOne substance-one assessmentZero Pollution AmbitionEnvironmental Science(all)SDG 3 - Good Health and Well-beingSDG 8 - Decent Work and Economic GrowthSDG 12 - Responsible Consumption and ProductionFunding Information: The authors are grateful to all experts from academia, institutes and industry that have participated in discussions that helped formulate the present strategy paper. They would also like to thank ISES Europe for initiating the discussions to prepare a European Exposure Science Strategy 2030. The German Federal Institute for Occupational Safety and Health (BauA), National Institute for Public Health and the Environment (RIVM) and the European Commission Joint Research Centre (JRC) are also acknowledged for each hosting of a meeting in 2018, 2019 and 2020 respectively during which the foundations of the current strategy were built. The views expressed are those of the authors alone and do not necessarily reflect those of the organisations at which they are employed. Publisher Copyright: © 2022 The AuthorsHuman biomonitoring (HBM) is a crucial approach for exposure assessment, as emphasised in the European Commission's Chemicals Strategy for Sustainability (CSS). HBM can help to improve chemical policies in five major key areas: (1) assessing internal and aggregate exposure in different target populations; 2) assessing exposure to chemicals across life stages; (3) assessing combined exposure to multiple chemicals (mixtures); (4) bridging regulatory silos on aggregate exposure; and (5) enhancing the effectiveness of risk management measures. In this strategy paper we propose a vision and a strategy for the use of HBM in chemical regulations and public health policy in Europe and beyond. We outline six strategic objectives and a roadmap to further strengthen HBM approaches and increase their implementation in the regulatory risk assessment of chemicals to enhance our understanding of exposure and health impacts, enabling timely and targeted policy interventions and risk management. These strategic objectives are: 1) further development of sampling strategies and sample preparation; 2) further development of chemical-analytical HBM methods; 3) improving harmonisation throughout the HBM research life cycle; 4) further development of quality control / quality assurance throughout the HBM research life cycle; 5) obtain sustained funding and reinforcement by legislation; and 6) extend target-specific communication with scientists, policymakers, citizens and other stakeholders. HBM approaches are essential in risk assessment to address scientific, regulatory and societal challenges. HBM requires full and strong support from the scientific and regulatory domain to reach its full potential in public and occupational health assessment and in regulatory decision-making.Centre for Toxicogenomics and Human Health (ToxOmics)NOVA Medical School|Faculdade de Ciências Médicas (NMS|FCM)Escola Nacional de Saúde Pública (ENSP)Comprehensive Health Research Centre (CHRC) - Pólo ENSPRUNZare Jeddi, MaryamHopf, Nancy B.Louro, HenriquetaViegas, SusanaGalea, Karen S.Pasanen-Kase, RobertSantonen, TiinaMustieles, VicenteFernandez, Mariana F.Verhagen, HansBopp, Stephanie K.Antignac, Jean PhilippeDavid, ArthurMol, HansBarouki, RobertAudouze, KarineDuca, Radu CorneliuFantke, PeterScheepers, PaulGhosh, ManosijVan Nieuwenhuyse, AnLobo Vicente, JoanaTrier, XeniaRambaud, LoïcFillol, ClémenceDenys, SebastienConrad, AndréKolossa-Gehring, MarikePaini, AliciaArnot, JonSchulze, FlorianJones, KateSepai, OvnairAli, ImranBrennan, LorraineBenfenati, EmilioCubadda, FrancescoMantovani, AlbertoBartonova, AlenaConnolly, AlisonSlobodnik, JaroslavBruinen de Bruin, Yurivan Klaveren, JacobPalmen, NicoleDirven, HubertHusøy, TrineThomsen, CathrineVirgolino, AnaRöösli, MartinGant, Timvon Goetz, NatalieBessems, Jos2022-09-23T22:18:27Z2022-102022-10-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10362/143991eng0160-4120PURE: 46558271https://doi.org/10.1016/j.envint.2022.107476info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2024-05-22T18:05:20Zoai:run.unl.pt:10362/143991Portal AgregadorONGhttps://www.rcaap.pt/oai/openairemluisa.alvim@gmail.comopendoar:71602024-05-22T18:05:20Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
Developing human biomonitoring as a 21st century toolbox within the European exposure science strategy 2020–2030 |
title |
Developing human biomonitoring as a 21st century toolbox within the European exposure science strategy 2020–2030 |
spellingShingle |
Developing human biomonitoring as a 21st century toolbox within the European exposure science strategy 2020–2030 Zare Jeddi, Maryam Chemicals mixtures Circular economy Data governance Human biomonitoring One substance-one assessment Zero Pollution Ambition Environmental Science(all) SDG 3 - Good Health and Well-being SDG 8 - Decent Work and Economic Growth SDG 12 - Responsible Consumption and Production |
title_short |
Developing human biomonitoring as a 21st century toolbox within the European exposure science strategy 2020–2030 |
title_full |
Developing human biomonitoring as a 21st century toolbox within the European exposure science strategy 2020–2030 |
title_fullStr |
Developing human biomonitoring as a 21st century toolbox within the European exposure science strategy 2020–2030 |
title_full_unstemmed |
Developing human biomonitoring as a 21st century toolbox within the European exposure science strategy 2020–2030 |
title_sort |
Developing human biomonitoring as a 21st century toolbox within the European exposure science strategy 2020–2030 |
author |
Zare Jeddi, Maryam |
author_facet |
Zare Jeddi, Maryam Hopf, Nancy B. Louro, Henriqueta Viegas, Susana Galea, Karen S. Pasanen-Kase, Robert Santonen, Tiina Mustieles, Vicente Fernandez, Mariana F. Verhagen, Hans Bopp, Stephanie K. Antignac, Jean Philippe David, Arthur Mol, Hans Barouki, Robert Audouze, Karine Duca, Radu Corneliu Fantke, Peter Scheepers, Paul Ghosh, Manosij Van Nieuwenhuyse, An Lobo Vicente, Joana Trier, Xenia Rambaud, Loïc Fillol, Clémence Denys, Sebastien Conrad, André Kolossa-Gehring, Marike Paini, Alicia Arnot, Jon Schulze, Florian Jones, Kate Sepai, Ovnair Ali, Imran Brennan, Lorraine Benfenati, Emilio Cubadda, Francesco Mantovani, Alberto Bartonova, Alena Connolly, Alison Slobodnik, Jaroslav Bruinen de Bruin, Yuri van Klaveren, Jacob Palmen, Nicole Dirven, Hubert Husøy, Trine Thomsen, Cathrine Virgolino, Ana Röösli, Martin Gant, Tim von Goetz, Natalie Bessems, Jos |
author_role |
author |
author2 |
Hopf, Nancy B. Louro, Henriqueta Viegas, Susana Galea, Karen S. Pasanen-Kase, Robert Santonen, Tiina Mustieles, Vicente Fernandez, Mariana F. Verhagen, Hans Bopp, Stephanie K. Antignac, Jean Philippe David, Arthur Mol, Hans Barouki, Robert Audouze, Karine Duca, Radu Corneliu Fantke, Peter Scheepers, Paul Ghosh, Manosij Van Nieuwenhuyse, An Lobo Vicente, Joana Trier, Xenia Rambaud, Loïc Fillol, Clémence Denys, Sebastien Conrad, André Kolossa-Gehring, Marike Paini, Alicia Arnot, Jon Schulze, Florian Jones, Kate Sepai, Ovnair Ali, Imran Brennan, Lorraine Benfenati, Emilio Cubadda, Francesco Mantovani, Alberto Bartonova, Alena Connolly, Alison Slobodnik, Jaroslav Bruinen de Bruin, Yuri van Klaveren, Jacob Palmen, Nicole Dirven, Hubert Husøy, Trine Thomsen, Cathrine Virgolino, Ana Röösli, Martin Gant, Tim von Goetz, Natalie Bessems, Jos |
author2_role |
author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author |
dc.contributor.none.fl_str_mv |
Centre for Toxicogenomics and Human Health (ToxOmics) NOVA Medical School|Faculdade de Ciências Médicas (NMS|FCM) Escola Nacional de Saúde Pública (ENSP) Comprehensive Health Research Centre (CHRC) - Pólo ENSP RUN |
dc.contributor.author.fl_str_mv |
Zare Jeddi, Maryam Hopf, Nancy B. Louro, Henriqueta Viegas, Susana Galea, Karen S. Pasanen-Kase, Robert Santonen, Tiina Mustieles, Vicente Fernandez, Mariana F. Verhagen, Hans Bopp, Stephanie K. Antignac, Jean Philippe David, Arthur Mol, Hans Barouki, Robert Audouze, Karine Duca, Radu Corneliu Fantke, Peter Scheepers, Paul Ghosh, Manosij Van Nieuwenhuyse, An Lobo Vicente, Joana Trier, Xenia Rambaud, Loïc Fillol, Clémence Denys, Sebastien Conrad, André Kolossa-Gehring, Marike Paini, Alicia Arnot, Jon Schulze, Florian Jones, Kate Sepai, Ovnair Ali, Imran Brennan, Lorraine Benfenati, Emilio Cubadda, Francesco Mantovani, Alberto Bartonova, Alena Connolly, Alison Slobodnik, Jaroslav Bruinen de Bruin, Yuri van Klaveren, Jacob Palmen, Nicole Dirven, Hubert Husøy, Trine Thomsen, Cathrine Virgolino, Ana Röösli, Martin Gant, Tim von Goetz, Natalie Bessems, Jos |
dc.subject.por.fl_str_mv |
Chemicals mixtures Circular economy Data governance Human biomonitoring One substance-one assessment Zero Pollution Ambition Environmental Science(all) SDG 3 - Good Health and Well-being SDG 8 - Decent Work and Economic Growth SDG 12 - Responsible Consumption and Production |
topic |
Chemicals mixtures Circular economy Data governance Human biomonitoring One substance-one assessment Zero Pollution Ambition Environmental Science(all) SDG 3 - Good Health and Well-being SDG 8 - Decent Work and Economic Growth SDG 12 - Responsible Consumption and Production |
description |
Funding Information: The authors are grateful to all experts from academia, institutes and industry that have participated in discussions that helped formulate the present strategy paper. They would also like to thank ISES Europe for initiating the discussions to prepare a European Exposure Science Strategy 2030. The German Federal Institute for Occupational Safety and Health (BauA), National Institute for Public Health and the Environment (RIVM) and the European Commission Joint Research Centre (JRC) are also acknowledged for each hosting of a meeting in 2018, 2019 and 2020 respectively during which the foundations of the current strategy were built. The views expressed are those of the authors alone and do not necessarily reflect those of the organisations at which they are employed. Publisher Copyright: © 2022 The Authors |
publishDate |
2022 |
dc.date.none.fl_str_mv |
2022-09-23T22:18:27Z 2022-10 2022-10-01T00:00:00Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://hdl.handle.net/10362/143991 |
url |
http://hdl.handle.net/10362/143991 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
0160-4120 PURE: 46558271 https://doi.org/10.1016/j.envint.2022.107476 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.source.none.fl_str_mv |
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
mluisa.alvim@gmail.com |
_version_ |
1817545888647610368 |